periodontal disease gingivae inflammation
Conditions
Interventions
After obtaining consent, a preliminary examination will be conducted, including a periodontitis test and oral function tests (saliva volume measurement, tongue coating evaluation, oral dryness evaluat
D010512
periodontal treatment
Sponsors
Mizuno Noriyoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with periodontitis 2. Patients who are 18 years of age or older at the time of obtaining consent. 3. Patients who are able to visit the clinic in the same time on the study start date and 7 days thereafter. 4. Patients who can provide written consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients whose living environment will change during the intervention period. 2. Patients who have taken oral or intravenous antibiotics or eye drops within 14 days prior to the start of the intervention. 3. Patients who have taken oral or intravenous immunosuppressants or steroids within 14 days prior to the start of the intervention. 4. Patients with less than 20% of plaque control records (PCR: a method of evaluating brushing based on plaque adhesion) prior to the start of the intervention. 5. Patients who have difficulty holding a toothbrush.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bad breath measurement (measurement of volatile sulfur compound concentration in breath using OralChroma) | — |
Secondary
| Measure | Time frame |
|---|---|
| PISA (Periodontal Inflamed Surface Area) Saliva volume measurement Tongue coating degree (TCI Oral dryness using the Mucus oral moisture mete Saliva viscosity using the NEVA METER Biting force test Chewing function using Glucosensor II Quantification of periodontal pathogenic bacteria (ORCOA) Measurement of oral bacterial load | — |
Contacts
Public ContactKazuhisa Ouhara
Hiroshima University Hospital
Outcome results
None listed